Clinical Trials Logo

Lung Metastasis clinical trials

View clinical trials related to Lung Metastasis.

Filter by:
  • None
  • Page 1

NCT ID: NCT05844761 Enrolling by invitation - Cancer of Prostate Clinical Trials

Real-time Motion Management During Prostate and Lung Radiotherapy

REMIND
Start date: May 1, 2023
Phase: N/A
Study type: Interventional

The goal of this interventional non-inferiority trial is to assess the accuracy of different real-time motion management radiotherapy techniques. The main question the study aims to answer are: - What are the target margins for radiotherapy with motion management that are not inferior to target margin without motion management - What are the dosimetric and geometrical accuracy to patient for the motion management techniques. Participants will answer QoL questionary, and the accuracy of treatment will be assessed from treatment data.

NCT ID: NCT04942275 Active, not recruiting - Clinical trials for Non-small Cell Lung Cancer

Lung Perfusion PET / CT Using Ga68-MAA for Preservation of Lung Function During Stereotactic Pulmonary Radiation Therapy

PEGASUS
Start date: July 15, 2021
Phase: Phase 2/Phase 3
Study type: Interventional

This is a prospective study evaluating the feasibility of treatment planning integrating lung perfusion PET/CT using Ga68-MAA to preserve functional lung areas during stereotactic body radiation therapy (SBRT).

NCT ID: NCT04753918 Not yet recruiting - Clinical trials for Non-small Cell Lung Cancer (NSCLC)

Novel Light Delivery Methods for Lung Cancer Photodynamic Therapy - A Pilot Study

Start date: March 2021
Phase: Early Phase 1
Study type: Interventional

This research study is being conducted to assess the safety and feasibility of using a newly developed bronchoscopic light delivery method of photodynamic therapy to treat subjects with solid tumors in peripheral lung, who are inoperable or refused surgery.

NCT ID: NCT02916745 Completed - Clinical trials for Non-small Cell Lung Cancer (NSCLC)

Feasibility Study of Using Navigational Bronchoscopy to Perform PDT-Photofrin® in Unresectable Peripheral Lung Cancer

Start date: January 26, 2017
Phase: Phase 1
Study type: Interventional

This research study is being conducted to assess the safety and feasibility of using a new developed bronchoscopic technology called electronavigational bronchoscopy to treat subjects with solid tumor in peripheral lung, who are inoperable or refused surgery. It will involve 10 sites in USA and Canada. Participation will last 6 months.

NCT ID: NCT01953406 Withdrawn - Clinical trials for Hepatocellular Carcinoma

The Efficacy of 5-fluorouracil/Mitomycin for the Patients With Pulmonary Metastasis of Hepatocellular Carcinoma

Start date: November 2015
Phase: Phase 2
Study type: Interventional

The aim of this study is to evaluate the efficacy of 5-fluorouracil + Mitomycin for the patients with pulmonary metastasis of hepatocellular carcinoma who had progressive disease with sorafenib.

NCT ID: NCT01923987 Recruiting - Rectal Cancer Clinical Trials

Short Course Radiotherapy Followed Intensive Chemotherapy With Delayed Surgery for Rectal Cancer With Synchronous Distant Metastasis

Start date: August 2012
Phase: Phase 2
Study type: Interventional

Radical treatment of primary rectal cancer with synchronous distant metastases includes surgical resection of primary and metastatic lesion. However, primary rectal cancer in case of metastasized disease are often locally advanced disease and need downsizing before surgery. It is reported that pelvic recurrence rates and distant metastasis rates outside liver are 30~35% and 60%, respectively. Therefore, combined treatment with radiotherapy and chemotherapy is used. However, the sequence of treatment modalities is not yet definitely established and preoperative chemoradiotherapy and surgical resection is accepted as an option of treatment. Conventional long course chemoradiotherapy delays administration of full-dose chemotherapy, and metastatic lesion can be progressed during chemoradiotherapy. In present study, we evaluate the efficacy of short course radiotherapy (SCRT) followed by full-dose chemotherapy with delayed surgical resection of the primary tumor and metastases.

NCT ID: NCT01612481 Terminated - Soft Tissue Sarcoma Clinical Trials

Phase II Study Evaluating Strategies of Lung Surveillance of Patients Operated of High Grade Soft Tissue Sarcoma

Start date: April 2012
Phase: Phase 2
Study type: Interventional

Cancer surveillance has a significant cost and generate anxiety for the patient. It is important to avoid exams that will not modify health support or whose results wont allow to decide.

NCT ID: NCT00776399 Completed - Colorectal Cancer Clinical Trials

Radiofrequency Ablation in Resectable Colorectal Lung Metastasis

Start date: October 2008
Phase: Phase 2
Study type: Interventional

Lung metastasectomy is the only therapeutic option to provide a long-survival in patients with colorectal lung metastases. Recent studies have shown that radiofrequency (RF) ablation is a safe and useful therapeutic option for the treatment of unresectable lung metastases. In this phase-II trial, clinical utility of lung RF ablation will be evaluated in patients with resectable colorectal lung metastases.

NCT ID: NCT00610844 Completed - Lung Cancer Clinical Trials

Preoperative Percutaneous Radiofrequency Ablation of Primary and Secondary Lung Tumors

Start date: April 2004
Phase: Phase 2
Study type: Interventional

The purpose of the study is to evaluate the effectiveness of radiofrequency ablation by pathological correlation and to characterize the tissue response after treatment of primary and secondary pulmonary tumors.